Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer
Biliary tract cancers (BTCs), for their low incidence, have been often considered together. Gallbladder cancer (GBC) is the most common biliary tract malignancy, characterized by late diagnosis and poor prognosis, and although it is considered a rare tumor in western countries, other areas of the wo...
Enregistré dans:
Auteurs principaux: | Matteo Canale, Manlio Monti, Ilario Giovanni Rapposelli, Paola Ulivi, Francesco Giulio Sullo, Giulia Bartolini, Elisa Tiberi, Giovanni Luca Frassineti |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/16b026a0d3554b54ae9b39c9fb66b95d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
KIF15 knockdown suppresses gallbladder cancer development
par: Jun Wang, et autres
Publié: (2021) -
Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications
par: Hendrien Kuipers, et autres
Publié: (2021) -
Outcome of routine histopathological examination of gallbladder specimen following elective laparoscopic cholecystectomy
par: Ashesh Kumar Jha, et autres
Publié: (2021) -
Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
par: Paola Ulivi, et autres
Publié: (2021) -
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor
par: García,Patricia, et autres
Publié: (2020)